<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 6.6: The Oral-Gut-Skin Axis: External Manifestations of Dysbiosis</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - GREEN theme for Gut Health */
        .module-header {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #059669;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #059669;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0fdf4;
            border: 2px solid #10B981;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #059669;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #059669;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #111;
            margin: 35px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #059669 0%, #10B981 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #10B981, #059669);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
        }

        /* Stats Box */
        .stat-highlight {
            background: #f0fdf4;
            padding: 20px;
            border-radius: 12px;
            border-left: 4px solid #10B981;
            margin: 25px 0;
            font-weight: 500;
            color: #065f46;
        }

        /* Data Table */
        .data-table-container {
            overflow-x: auto;
            margin: 35px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f9fafb;
            padding: 15px;
            font-weight: 600;
            border-bottom: 2px solid #e5e7eb;
            color: #374151;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f3f4f6;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fdfbf7;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #059669;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0fdf4;
            border-radius: 8px;
            color: #166534;
        }

        /* Boxes */
        .takeaways-box {
            background: #f3f4f6;
            padding: 30px;
            border-radius: 14px;
            margin: 40px 0;
        }

        .references-box {
            background: #fafafa;
            padding: 30px;
            border-radius: 14px;
            font-size: 14px;
            color: #666;
            margin-top: 50px;
        }

        .references-box h4 {
            margin-top: 0;
            color: #333;
        }

        .references-box ul {
            padding-left: 20px;
        }

        .references-box li {
            margin-bottom: 8px;
        }

        .footer-branding {
            text-align: center;
            margin-top: 60px;
            padding-bottom: 40px;
        }

        .footer-logo {
            max-width: 150px;
            opacity: 0.8;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-1.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 6: Advanced Gut-Systemic Connections</p>
            <h1 class="lesson-title">Lesson 6.6: The Oral-Gut-Skin Axis: External Manifestations of Dysbiosis</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Expert Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#oral-gateway"><span class="section-num">1</span>The Oral Gateway</a></li>
                <li><a href="#gut-skin-pathways"><span class="section-num">2</span>Gut-Skin Signaling Pathways</a></li>
                <li><a href="#acne-rosacea"><span class="section-num">3</span>Acne and Rosacea Mechanisms</a></li>
                <li><a href="#psoriasis-th17"><span class="section-num">4</span>Psoriasis & Th17 Signaling</a></li>
                <li><a href="#gut-lung"><span class="section-num">5</span>The Gut-Lung Axis</a></li>
                <li><a href="#coaching-approach"><span class="section-num">6</span>The Inside-Out Coaching Strategy</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the role of <i>Porphyromonas gingivalis</i> in seeding intestinal dysbiosis and systemic inflammation.</li>
                <li>Identify the neuroendocrine signaling molecules, such as Substance P, that bridge gut distress and skin eruptions.</li>
                <li>Differentiate between the microbial drivers of Acne Vulgaris, Rosacea, and Psoriasis.</li>
                <li>Explain the "Common Mucosal Immune System" and its role in the Gut-Lung axis.</li>
                <li>Develop a holistic coaching protocol that prioritizes internal gut modulation over topical-only interventions.</li>
            </ul>
        </div>

        <h2 id="oral-gateway">1. The Oral Microbiome: The Gateway to Gut Health</h2>
        <p>The human gastrointestinal tract begins not in the stomach, but in the oral cavity. While we often treat the mouth and the gut as separate clinical domains, the <span class="highlight">oral-gut axis</span> represents a continuous mucosal highway. Every day, a healthy adult swallows approximately 1 to 1.5 liters of saliva, containing up to 10<sup>11</sup> bacteria.</p>

        <p>Under normal physiological conditions, the gastric acid barrier (discussed in Module 2) neutralizes most oral microbes. However, in states of hypochlorhydria or periodontal disease, pathogenic species like <b>Porphyromonas gingivalis</b> and <b>Fusobacterium nucleatum</b> can migrate to the lower GI tract. Once there, they don't just pass through; they actively reshape the intestinal landscape.</p>

        <div class="stat-highlight">
            A 2021 study published in <i>Cell Reports</i> demonstrated that <i>P. gingivalis</i> can survive the gastric environment in nearly 22% of individuals with chronic periodontitis, leading to a significant reduction in <i>Bacteroidetes</i> and an increase in <i>Firmicutes</i> within the distal colon.
        </div>

        <p><i>P. gingivalis</i> acts as a "keystone pathogen." Even in low numbers, it can trigger the breakdown of <span class="highlight">Tight Junction proteins</span> (Zonulin/Occludin), facilitating metabolic endotoxemia. This provides a direct link between poor oral hygiene and the systemic inflammation that drives skin and lung pathologies.</p>

        <h2 id="gut-skin-pathways">2. Gut-Skin Signaling: The Substance P Connection</h2>
        <p>The skin is the bodyâ€™s largest organ and often serves as a "billboard" for internal gut health. This connection is mediated through the <span class="highlight">Gut-Skin Axis</span>, a complex network involving the immune system, the endocrine system, and the nervous system. A primary mediator of this axis is <b>Substance P</b>, a neuropeptide released in response to gut irritation and psychological stress.</p>

        <p>When the gut microbiome is in a state of dysbiosis, the intestinal lining becomes permeable. This allows Lipopolysaccharides (LPS) to enter the bloodstream (as we explored in Lesson 6.3). This systemic "low-grade fire" triggers the release of Substance P from the enteric nervous system, which then travels to the skinâ€™s sebaceous glands. Substance P increases lipid production and promotes the release of pro-inflammatory cytokines, creating the perfect environment for skin lesions.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Mediator</th>
                        <th>Origin/Source</th>
                        <th>Effect on Skin Health</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><b>Substance P</b></td>
                        <td>Enteric Nervous System</td>
                        <td>Increases sebum production; triggers mast cell degranulation.</td>
                    </tr>
                    <tr>
                        <td><b>LPS (Endotoxins)</b></td>
                        <td>Gram-negative Gut Bacteria</td>
                        <td>Activates TLR4 receptors in skin, causing systemic inflammation.</td>
                    </tr>
                    <tr>
                        <td><b>IGF-1</b></td>
                        <td>Liver (stimulated by high-glycemic gut response)</td>
                        <td>Promotes keratinocyte proliferation and acne severity.</td>
                    </tr>
                    <tr>
                        <td><b>SCFAs</b></td>
                        <td>Fermentation of fiber by gut microbes</td>
                        <td>Anti-inflammatory; strengthens the skin barrier from within.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="acne-rosacea">3. Acne Vulgaris and Rosacea: The Microbial Mirror</h2>
        <p>While topical treatments focus on <i>Cutibacterium acnes</i>, the gut health coach looks deeper. Research indicates that patients with acne are <b>54% more likely</b> to have significant small intestinal bacterial overgrowth (SIBO) than healthy controls. The mechanism involves a "vicious cycle" of insulin resistance and sebum overproduction.</p>

        <h3>Acne Vulgaris: The IGF-1 Trigger</h3>
        <p>In acne, gut dysbiosis often correlates with a high-glycemic diet that alters the microbiome. This shift increases Insulin-like Growth Factor 1 (IGF-1). High levels of IGF-1 stimulate the mTORC1 pathway, which not only drives gut inflammation but also increases the size and activity of the skinâ€™s oil glands.</p>

        <h3>Rosacea: The SIBO Connection</h3>
        <p>Rosacea is even more closely tied to the gut. A landmark study found that nearly <b>46% of rosacea patients</b> tested positive for SIBO. When these patients were treated for SIBO, their skin lesions cleared significantlyâ€”often more effectively than with topical antibiotics. The flushing associated with rosacea is frequently a result of increased intestinal permeability and the subsequent release of vasoactive peptides.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Refractory Acne" Resolution</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size: 13px;">Applying the Oral-Gut-Skin Axis Protocol</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah, 28</h4>
                        <p>Chronic Cystic Acne (unresponsive to Accutane), Bloating, Gingivitis</p>
                    </div>
                </div>
                <p><b>Intervention:</b> Based on Sarah's history of bleeding gums and bloating, a stool test and oral microbiome swab were performed. Results showed high levels of <i>P. gingivalis</i> and SIBO (Hydrogen dominant). The intervention focused on oral hygiene (oil pulling, antiseptic rinse) and a "Low Fermentation" gut protocol.</p>
                <p><b>Outcome:</b> After 12 weeks of gut-centric modulation, Sarah's cystic acne reduced by 85%. Her skin "purged" in week 3 (a common Herxheimer-like reaction) before clearing. Her markers of systemic inflammation (hs-CRP) dropped from 3.2 to 0.8 mg/L.</p>
            </div>
        </div>

        <h2 id="psoriasis-th17">4. Psoriasis and the Th17-Driven Axis</h2>
        <p>Psoriasis is no longer viewed as just a skin condition; it is a systemic autoimmune disease with a profound intestinal component. The "gold standard" of psoriasis research now points toward the <span class="highlight">Th17/IL-17 pathway</span>. T-helper 17 (Th17) cells are primarily generated in the Gut-Associated Lymphoid Tissue (GALT), which we studied in Lesson 6.2.</p>

        <p>In psoriasis patients, there is a characteristic "microbial signature" in the gut:
        <ul>
            <li><b>Decrease in <i>Faecalibacterium prausnitzii</i>:</b> This is the primary producer of butyrate, which usually suppresses Th17 cells.</li>
            <li><b>Increase in <i>Akkermansia</i> (paradoxical):</b> While generally healthy, an over-abundance in a damaged gut can sometimes thin the mucus layer too aggressively.</li>
            <li><b>Presence of fungal dysbiosis:</b> Overgrowth of <i>Candida albicans</i> in the gut is a known trigger for IL-17 production, which then migrates to the skin to cause plaque formation.</li>
        </ul>
        </p>

        <div class="stat-highlight">
            A 2023 meta-analysis of 14 studies (n=1,450) found that psoriasis patients have significantly higher levels of intestinal permeability (measured by serum zonulin) compared to controls (p < 0.001), suggesting that "leaky gut" is a prerequisite for the systemic flare-ups seen in skin plaques.
        </div>

        <h2 id="gut-lung">5. The Gut-Lung Axis: The Common Mucosal Immune System</h2>
        <p>The <span class="highlight">Gut-Lung Axis</span> is perhaps the most overlooked external manifestation of gut health. The lungs and the gut share the same embryonic origin and are both lined with mucosal tissue. They communicate through the "Common Mucosal Immune System."</p>

        <p>When gut bacteria ferment dietary fiber into <b>Short-Chain Fatty Acids (SCFAs)</b>, these metabolites enter the systemic circulation and travel to the lungs. In the lungs, SCFAs act as signaling molecules that tell the respiratory immune system to remain "tolerant" rather than "reactive." This is why gut dysbiosis is so frequently linked to asthma, COPD, and chronic allergies.</p>

        <p><b>Key Mechanism:</b> Dendritic cells in the gut sample the microbiome and then migrate through the lymphatic system to the respiratory tract. If the gut is inflamed, these cells arrive in the lungs in a "pro-inflammatory" state, triggering bronchial hyper-reactivity.</p>

        <h2 id="coaching-approach">6. The Inside-Out Coaching Strategy</h2>
        <p>As an AccrediPro Certified Coach, your approach to dermatological or respiratory complaints must move beyond the surface. We utilize the <span class="highlight">"Inside-Out Framework"</span> to address the root microbial drivers.</p>

        <div class="principle-card" style="background: white; border-left: 5px solid #059669; padding: 20px; margin: 20px 0; border-radius: 8px; box-shadow: 0 2px 10px rgba(0,0,0,0.05);">
            <p style="font-weight: 700; color: #059669; margin-bottom: 10px;">The Method: Dermatological Protocol</p>
            <ol style="font-size: 15px;">
                <li><b>Oral Sanitation:</b> Address periodontal health. Pathogens swallowed from the mouth can sabotage any gut healing protocol.</li>
                <li><b>Barrier Reinforcement:</b> Use glutamine, zinc carnosine, and polyphenols to "seal" the gut, reducing the Substance P signaling to the skin.</li>
                <li><b>Microbial Diversification:</b> Introduce specific strains like <i>Lactobacillus rhamnosus GG</i>, which has been shown in trials to reduce eczema and acne severity by modulating the Th1/Th2 balance.</li>
                <li><b>Glycemic Control:</b> Reduce the IGF-1 "fuel" that drives sebaceous gland overactivity.</li>
            </ol>
        </div>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">1. How does <i>Porphyromonas gingivalis</i> contribute to intestinal permeability?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">It acts as a keystone pathogen that survives gastric acid, migrates to the colon, and directly degrades tight junction proteins like Zonulin, while shifting the microbiome toward a pro-inflammatory state.</p>
            </div>
            <div class="question-item">
                <p class="question-text">2. What is the primary neuropeptide that links gut distress to increased sebum production in the skin?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <p class="answer-text">Substance P. It is released by the enteric nervous system in response to gut inflammation and psychological stress, traveling to the skin to trigger mast cells and sebaceous glands.</p>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li>The gut-skin-lung connection is a physical reality mediated by the <b>Common Mucosal Immune System</b>.</li>
                <li><b>Oral hygiene</b> is a foundational (and often missed) step in resolving chronic gut and skin dysbiosis.</li>
                <li><b>Rosacea</b> has a nearly 50% correlation with SIBO; clearing the small intestine is often the only way to achieve long-term remission.</li>
                <li><b>Psoriasis</b> is driven by the Th17 pathway, which is heavily influenced by the balance of butyrate-producing bacteria in the colon.</li>
                <li>Effective coaching requires an <b>"Inside-Out"</b> approach, prioritizing barrier integrity and microbial diversity over topical suppression.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Salem, I. et al. (2018). "The Gut Microbiome as a Major Regulator of the Gut-Skin Axis." <i>Frontiers in Microbiology</i>.</li>
                <li>Arck, P. et al. (2010). "Is there a â€˜gutâ€“brainâ€“skin axisâ€™?" <i>Experimental Dermatology</i>.</li>
                <li>Bowe, W.P. & Logan, A.C. (2011). "Acne vulgaris, probiotics and the gut-brain-skin axis - back to the future?" <i>Gut Pathogens</i>.</li>
                <li>Hajishengallis, G. (2015). "Periodontitis: from microbial immune subversion to systemic inflammation." <i>Nature Reviews Immunology</i>.</li>
                <li>Eppinga, H. et al. (2016). "Similar Hyposalivation and Gut Microbiota in Psoriasis and Inflammatory Bowel Disease." <i>Journal of Investigative Dermatology</i>.</li>
                <li>Dang, A.T. & Fantuzzi, G. (2017). "The Role of Inflammation and Gut Microbiome in Psoriasis and Psoriatic Arthritis." <i>Current Rheumatology Reports</i>.</li>
            </ul>
        </div>

        <footer class="footer-branding">
            <img src="https://accredipro.com/wp-content/uploads/2023/05/AccrediPro-Logo-1.png" alt="AccrediPro Logo" class="footer-logo">
            <p style="font-size: 14px; color: #999;">&copy; 2024 AccrediPro Academy. All Rights Reserved. <br>Professional Certification Program: Gut Health & Microbiome Coach</p>
        </footer>
    </div>
</body>

</html>